histology colorectal carcinoma, therapy
Item
patients with histologically confirmed colorectal carcinoma for whom no other anti-cancer treatment was anticipated during the three month period of study.
boolean
C0019638 (UMLS CUI [1,1])
C0009402 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
proton pump inhibitor
Item
patients taking a proton pump inhibitor at a fixed daily dose which had remained unchanged for at least six weeks preceding screening and was not anticipated to change during the study.
boolean
C0358591 (UMLS CUI [1])
proton pump inhibitor compliance
Item
proton pump inhibitor compliance of ~70% (to be measured between screening and baseline (week 0)).
boolean
C0358591 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
gender, age
Item
male or female patients from 18 to 65 years of age.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
life expectancy
Item
patients with a life expectancy of over three months.
boolean
C0023671 (UMLS CUI [1])
who performance status
Item
world health organisation (who) performance status of 0 to 1.
boolean
C1298650 (UMLS CUI [1])
informed consent
Item
written informed consent given.
boolean
C0021430 (UMLS CUI [1])
histamine h2 antagonists, antiacids
Item
patients in receipt of histamine h2-receptor (h2 receptor) antagonists or any other antacid therapy, other than a proton pump inhibitor at a stable dose.
boolean
C0019593 (UMLS CUI [1])
C0003138 (UMLS CUI [2])
gastric acidity
Item
patients with any other factor likely to alter intra-gastric acidity e.g. previous gastric surgery, including vagotomy or anatomically abnormal upper gastrointestinal tract.
boolean
C0017120 (UMLS CUI [1])
malignancy
Item
history of other malignant disease within the previous five years, except non-
boolean
C0006826 (UMLS CUI [1])
melanoma, cervix carcinoma in situ
Item
melanomatous skin cancer or in situ carcinoma of the uterine cervix.
boolean
C0025202 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
radiotherapy, chemotherapy
Item
previous use within the last four weeks, concomitant use or anticipated use in the period of the study of radiotherapy or chemotherapy.
boolean
C1522449 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
immunosuppressants
Item
concomitant use of immunosuppressants, including systemic (i .e. oral or injected) corticosteroids.
boolean
C0021081 (UMLS CUI [1])
pregnancy, lactation
Item
females who were pregnant, planning to become pregnant or lactating. women, who in the opinion of the investigator were of child bearing potential, were to have a negative pregnancy test before study drug administration.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
study subject participation status
Item
patients taking part in another study involving an investigational or licensed drug or device in the three months preceding enrolment or during the study.
boolean
C2348568 (UMLS CUI [1])
G17DT
Item
previous g 17dt treatment.
boolean
C0935889 (UMLS CUI [1])
haemoglobin, wbc, platelet count
Item
haematological indicators: haemoglobin <10.0 g/dl white blood cell count <4.0 x 109/l platelets < 100 x 1 09/l
boolean
C0518015 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0032181 (UMLS CUI [3])